ストックスクリーナーアプリを入手
55.67
0.94%
0.52
アフターアワーズ：
56.00
0.33
+0.59%
前日終値:
$55.15
開ける：
$55.14
24時間の取引高:
581.99K
Relative Volume:
0.89
時価総額：
$2.13B
収益：
$17.39M
当期純損益:
$-135.89M
株価収益率:
-12.00
EPS:
-4.64
ネットキャッシュフロー:
$-123.00M
1週間 パフォーマンス:
+1.22%
1か月 パフォーマンス:
+10.46%
6か月 パフォーマンス:
+92.43%
1年 パフォーマンス:
+178.49%
1日の値動き範囲:
$54.18
$56.02
1週間の範囲:
$53.51
$57.14
52週間の値動き範囲:
$18.99
$57.14
Tarsus Pharmaceuticals Inc Stock (TARS) Company Profile
名前
Tarsus Pharmaceuticals Inc
セクター
電話
(949) 409-9820
住所
15440 LAGUNA CANYON ROAD, IRVINE
TARS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TARS
Tarsus Pharmaceuticals Inc
|
55.67 | 2.13B | 17.39M | -135.89M | -123.00M | -4.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.11 | 104.84B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.15 | 78.92B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
621.29 | 37.15B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.28 | 30.22B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
115.79 | 27.76B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tarsus Pharmaceuticals Inc Stock (TARS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-20 | 開始されました | Goldman | Neutral |
| 2023-07-18 | 開始されました | William Blair | Outperform |
| 2023-05-18 | 開始されました | Guggenheim | Buy |
| 2022-08-01 | 開始されました | Barclays | Overweight |
| 2021-12-21 | 開始されました | H.C. Wainwright | Buy |
| 2021-11-23 | 開始されました | Oppenheimer | Outperform |
| 2020-11-10 | 開始されました | BofA Securities | Buy |
| 2020-11-10 | 開始されました | Jefferies | Buy |
| 2020-11-10 | 開始されました | Ladenburg Thalmann | Buy |
| 2020-11-10 | 開始されました | Raymond James | Strong Buy |
すべてを表示
Tarsus Pharmaceuticals Inc (TARS) 最新ニュース
Tarsus PharmaceuticalEye Care Therapeutics - MSN
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Bought by Franklin Resources Inc. - Defense World
Tarsus Pharmaceuticals stock soars to 52-week high of $56.84 By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals (NASDAQ:TARS) Sets New 12-Month HighHere's What Happened - MarketBeat
Tarsus Pharmaceuticals stock soars to 52-week high of $56.84 - Investing.com
How Tarsus Pharmaceuticals' Unique Inspiration Is Driving A Triple-Digit Run - MSN
Geode Capital Management LLC Increases Stock Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
The Zacks Analyst Blog Highlights ADMA Biologics, Tarsus Pharmaceuticals, Stoke Therapeutics, Inc. and ChromaDex - Yahoo Finance
Comparing Tarsus Pharmaceuticals (NASDAQ:TARS) and CG Oncology (NASDAQ:CGON) - Defense World
Barclays PLC Grows Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Barclays PLC Boosts Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World
State Street Corp Sells 26,260 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Fmr LLC Buys 3,537 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Position Lessened by State Street Corp - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Hits New 52-Week HighHere's What Happened - MarketBeat
When the Price of (TARS) Talks, People Listen - Stock Traders Daily
Tarsus Pharmaceuticals: Worthy Of A Small Bet (NASDAQ:TARS)🤭 Experimente a diversão no C333Bet - Oficjalny Portal Gminy Brzesko
Wellington Management Group LLP Acquires 18,019 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals: Worthy Of A Small Bet (NASDAQ:TARS❌ Ilumine seu dia com Estrela BRT - Oficjalny Portal Gminy Brzesko
Tarsus Pharmaceuticals Insider Lowered Holding By 16% During Last Year - Simply Wall St
Lord Abbett & CO. LLC Acquires 131,636 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Bought by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's Top 2 Picks - Seeking Alpha
Tarsus Pharmaceuticals' SWOT analysis: eye care stock's growth trajectory By Investing.com - Investing.com Australia
Tarsus Pharmaceuticals' SWOT analysis: eye care stock's growth trajectory - Investing.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Down – Here’s What Happened - Defense World
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap DownTime to Sell? - MarketBeat
The Manufacturers Life Insurance Company Has $1.08 Million Stake in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
Tarsus Pharmaceuticals Stock Hits 52-Week High at $53.02 By Investing.com - Investing.com South Africa
Tarsus Pharmaceuticals Stock Hits 52-Week High at $53.02 - Investing.com
Tarsus Pharmaceuticals: Early Rollout Exceeding Expectations (NASDAQ:TARS) - Seeking Alpha
Charles Schwab Investment Management Inc. Buys 28,130 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Charles Schwab Investment Management Inc. Boosts Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World
23,199 Shares in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Purchased by Verition Fund Management LLC - MarketBeat
Wall Street Analysts Think Tarsus Pharmaceuticals (TARS) Could Surge 26.98%: Read This Before Placing a Bet - MSN
Tarsus stock Buy rating intact as Guggenheim tracks Xdemvy's Demodex blepharitis launch - Investing.com UK
Vestal Point Capital LP Invests $7.57 Million in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Healthcare of Ontario Pension Plan Trust Fund Trims Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Analysts Set Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) PT at $54.20 - MarketBeat
Ally Bridge Group NY LLC Makes New $10.59 Million Investment in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Reduces Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Midday Stock Roundup: Chipotle stock up as chain announces 2% hike in menu prices - Orange County Business Journal
Tarsus Pharmaceuticals' SWOT analysis: XDEMVY success drives stock outlook - Investing.com
Mutual of America Capital Management LLC Invests $4.29 Million in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Jennison Associates LLC Buys 698,712 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - MSN
Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's is How to Trade - MSN
The Goldman Sachs Group Boosts Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $41.00 - Defense World
Tarsus Pharmaceuticals Inc (TARS) 財務データ
収益
当期純利益
現金流量
EPS
0.60%
2.24%
大文字化:
|
ボリューム (24 時間):